表紙:癌性疼痛:パイプライン製品の分析
市場調査レポート
商品コード
192514

癌性疼痛:パイプライン製品の分析

Cancer Pain (Central Nervous System) - Drugs in Development, 2021

出版日: | 発行: Global Markets Direct | ページ情報: 英文 169 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
癌性疼痛:パイプライン製品の分析
出版日: 2021年09月30日
発行: Global Markets Direct
ページ情報: 英文 169 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

癌性疼痛とは、癌による人体への損傷と、その損傷への人体の反応とが複雑に組み合わさった感覚だと定義することができます。疼痛は、腫瘍による人体組織の圧迫や浸潤、治療・診断のための処置、免疫反応やホルモン放出による皮膚・神経などの変形などに伴って発生します。鎮痛剤療法やオピオイド鎮痛薬、アジュバント薬(佐薬)、心理療法、麻酔学的・神経外科学的な疼痛管理手法などにより、癌性疼痛を治療することができます。

当レポートでは、世界各国での癌性疼痛治療用のパイプライン製品の開発状況について分析し、製品開発・上市の最新動向や、治験の各段階にある製品の一覧、主要企業のプロファイル、主な薬剤の概要、最新の業界動向などの情報をお届けします。

イントロダクション

癌性疼痛:概要

治療薬の開発

治療薬の評価

治療薬開発に従事している企業

薬剤プロファイル

休止中のプロジェクト

開発が中止された製品

製品開発のマイルストーン

付録

図表一覧

図表

List of Tables

List of Tables

  • Number of Products under Development for Cancer Pain, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Companies, 2021 (Contd..1)
  • Number of Products under Development by Companies, 2021 (Contd..2)
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Companies, 2021 (Contd..1)
  • Products under Development by Companies, 2021 (Contd..2)
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Target, 2021 (Contd..1)
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Cancer Pain - Pipeline by AfaSci Inc, 2021
  • Cancer Pain - Pipeline by Alexza Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by AngioChem Inc, 2021
  • Cancer Pain - Pipeline by Aphios Corp, 2021
  • Cancer Pain - Pipeline by Aquilus Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by AstraZeneca Plc, 2021
  • Cancer Pain - Pipeline by Beckley Canopy Therapeutics Ltd, 2021
  • Cancer Pain - Pipeline by Bisichem Co Ltd, 2021
  • Cancer Pain - Pipeline by Cassava Sciences Inc, 2021
  • Cancer Pain - Pipeline by Chengdu Easton Biopharmaceuticals Co Ltd, 2021
  • Cancer Pain - Pipeline by Concentric Analgesics Inc, 2021
  • Cancer Pain - Pipeline by Fujimoto Pharmaceutical Corp, 2021
  • Cancer Pain - Pipeline by IACTA Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by Indaptus Therapeutics Inc, 2021
  • Cancer Pain - Pipeline by IntelGenx Corp, 2021
  • Cancer Pain - Pipeline by iX Biopharma Ltd, 2021
  • Cancer Pain - Pipeline by Jiangsu Huatai Chenguang Pharmaceutical Co Ltd, 2021
  • Cancer Pain - Pipeline by Klaria Pharma Holding AB, 2021
  • Cancer Pain - Pipeline by Komipharm International Co Ltd, 2021
  • Cancer Pain - Pipeline by Luye Pharma Group Ltd, 2021
  • Cancer Pain - Pipeline by Medlab Clinical Ltd, 2021
  • Cancer Pain - Pipeline by Mundipharma International Ltd, 2021
  • Cancer Pain - Pipeline by Nanomerics Ltd, 2021
  • Cancer Pain - Pipeline by Neurocentrx Pharma Ltd, 2021
  • Cancer Pain - Pipeline by Nippon Zoki Pharmaceutical Co Ltd, 2021
  • Cancer Pain - Pipeline by Orion Corp, 2021
  • Cancer Pain - Pipeline by Pfizer Inc, 2021
  • Cancer Pain - Pipeline by ProNeurogen Inc, 2021
  • Cancer Pain - Pipeline by Quell Therapeutics Ltd, 2021
  • Cancer Pain - Pipeline by Ribomic Inc, 2021
  • Cancer Pain - Pipeline by Sedor Pharmaceuticals LLC, 2021
  • Cancer Pain - Pipeline by Shandong Boan Biotechnology Co Ltd, 2021
  • Cancer Pain - Pipeline by Sorrento Therapeutics Inc, 2021
  • Cancer Pain - Pipeline by Tetra Bio-Pharma Inc, 2021
  • Cancer Pain - Pipeline by Tris Pharma Inc, 2021
  • Cancer Pain - Pipeline by Virpax Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by WEX Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by Winston Pharmaceuticals Inc, 2021
  • Cancer Pain - Pipeline by Yichang Renfu Pharmaceutical Co Ltd, 2021
  • Cancer Pain - Pipeline by Yongzhan International Pharmaceutical Co Ltd, 2021
  • Cancer Pain - Dormant Projects, 2021
  • Cancer Pain - Dormant Projects, 2021 (Contd..1)
  • Cancer Pain - Dormant Projects, 2021 (Contd..2)
  • Cancer Pain - Dormant Projects, 2021 (Contd..3)
  • Cancer Pain - Discontinued Products, 2021

List of Figures

List of Figures

  • Number of Products under Development for Cancer Pain, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Molecule Types, 2021
  • Number of Products by Stage and Molecule Types, 2021
目次
Product Code: GMDHC13071IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2021, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape.Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tissue, from treatments and diagnostic procedures, or from skin, nerve and other changes caused by either the body's immune response or hormones released by the tumor. Cancer pain can be treated by analgesic drug therapy, non-opioid analgesics, opioid analgesics, adjuvant drugs, psychotherapy, anesthetic and neurosurgical pain management.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cancer Pain - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Cancer Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Cancer Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cancer Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 7, 8, 2, 20, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Cancer Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Cancer Pain (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Cancer Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Cancer Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Cancer Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Cancer Pain (Central Nervous System)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Cancer Pain (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Cancer Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Cancer Pain - Overview
  • Cancer Pain - Therapeutics Development
  • Cancer Pain - Therapeutics Assessment
  • Cancer Pain - Companies Involved in Therapeutics Development
  • Cancer Pain - Drug Profiles
  • Cancer Pain - Dormant Projects
  • Cancer Pain - Discontinued Products
  • Cancer Pain - Product Development Milestones
  • Appendix